Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.62 |
| ▸ | MEN1 | O00255 | 3/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | ATM | Q13315 | 2/20 | 0.34 |
| ▸ | MITF | O75030 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | PDCD1 | Q15116 | 2/20 | 0.32 |
| ▸ | CD274 | Q9NZQ7 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27586182 | 1.00 | KMT2A (0.62) | KMT2AMEN1L3MBTL1ALDH1A1CYP2C19 | |
| SCHEMBL17590137 | 1.00 | KMT2A (0.62) | KMT2AMEN1L3MBTL1ALDH1A1CYP2C19 | |
| SCHEMBL12659164 | 1.00 | KMT2A (0.62) | KMT2AMEN1L3MBTL1ALDH1A1CYP2C19 | |
| SCHEMBL7150024 | 0.90 | KMT2A (0.63) | KMT2AMEN1L3MBTL1ALDH1A1CYP2C19 | |
| SCHEMBL17590134 | 0.87 | KMT2A (0.50) | KMT2AMEN1L3MBTL1ALDH1A1CYP2C19 | |
| SCHEMBL12659165 | 0.87 | KMT2A (0.50) | KMT2AMEN1L3MBTL1ALDH1A1CYP2C19 | |
| SCHEMBL29306273 | 0.87 | KMT2A (0.60) | KMT2AMEN1L3MBTL1ALDH1A1CYP2C19 | |
| SCHEMBL13380989 | 0.83 | KMT2A (0.69) | KMT2AMEN1L3MBTL1ALDH1A1CYP2C19 | |
| SCHEMBL13743115 | 0.83 | KMT2A (0.69) | KMT2AMEN1L3MBTL1ALDH1A1CYP2C19 | |
| SCHEMBL10238940 | 0.83 | KMT2A (0.69) | KMT2AMEN1L3MBTL1ALDH1A1CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8288515-B2 | Process for preparing Fondaparinux sodium and intermediates useful in the synthesis thereof | RELIABLE BIOPHARMACEUTICAL CORPORATION (US) | 2012-10-16 | — | — | US | disclosed |
| US-20110105418-A1 | PROCESS FOR PREPARING FONDAPARINUX SODIUM AND INTERMEDIATES USEFUL IN THE SYNTHESIS THEREOF | RELIABLE BIOPHARMACEUTICAL CORPORATION (US) | 2011-05-05 | — | — | US | disclosed |
| WO-2011014793-A9 | PROCESS FOR PREPARING FONDAPARINUX SODIUM AND INTERMEDIATES USEFUL IN THE SYNTHESIS THEREOF | RELIABLE BIOPHARMACEUTICAL CORPORATION (US) | 2011-03-24 | — | — | WO | disclosed |
| WO-2011014793-A2 | PROCESS FOR PREPARING FONDAPARINUX SODIUM AND INTERMEDIATES USEFUL IN THE SYNTHESIS THEREOF | RELIABLE BIOPHARMACEUTICAL CORPORATION (US) | 2011-02-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110105418-A1 | PROCESS FOR PREPARING FONDAPARINUX SODIUM AND INTERMEDIATES USEFUL IN THE SYNTHESIS THEREOF | F11, TFPI, STS | KMT2A 2999/4885MEN1 1877/4885L3MBTL1 4103/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.